Literature DB >> 18475461

Serum levels of interleukin-6 are not dependent on the kidney function.

L Nässberger1.   

Abstract

Interleukin-6, also named B-cell stimulatory factor, is a glycoprotein with a molecular weight of 26 kDa. Increased serum levels of interleukin-6 (IL-6) are found in several disease conditions. We investigated the importance of a deteriorated kidney function upon IL-6 serum concentrations. No relation was found between serum levels of IL-6 and s-creatinine, r = 0.004. On the other hand, the serum concentration of complement protein factor D and soluble IL-2 receptor showed a good correlation to s-creatinine, r = 0.92 and 0.79, respectively. In conclusion, serum levels of IL-6 are not dependent upon a reduced kidney function.

Entities:  

Year:  1992        PMID: 18475461      PMCID: PMC2365338          DOI: 10.1155/S0962935192000309

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  23 in total

1.  Increased plasma interleukin 6 and renin substrate levels during bacterial peritonitis in CAPD patients.

Authors:  K Metsärinne; A M Teppo; C Grönhagen-Riska; F Fyhrquist
Journal:  Clin Nephrol       Date:  1991-08       Impact factor: 0.975

2.  Pharmacokinetics of recombinant interleukin 2 in humans.

Authors:  M W Konrad; G Hemstreet; E M Hersh; P W Mansell; R Mertelsmann; J E Kolitz; E C Bradley
Journal:  Cancer Res       Date:  1990-04-01       Impact factor: 12.701

3.  Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation.

Authors:  N Nishimoto; K Yoshizaki; H Tagoh; M Monden; S Kishimoto; T Hirano; T Kishimoto
Journal:  Clin Immunol Immunopathol       Date:  1989-03

4.  Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation.

Authors:  A Martin; P J Lachmann; L Halbwachs; M J Hobart
Journal:  Immunochemistry       Date:  1976-04

5.  The effects of psychological stress on plasma interleukin-6 activity in rats.

Authors:  L G LeMay; A J Vander; M J Kluger
Journal:  Physiol Behav       Date:  1990-05

Review 6.  Interactions between cytokines and alpha 2-macroglobulin.

Authors:  K James
Journal:  Immunol Today       Date:  1990-05

7.  Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor.

Authors:  P Seckinger; J H Zhang; B Hauptmann; J M Dayer
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

Review 8.  Autoantibodies to cytokines--friends or foes?

Authors:  K Bendtzen; M Svenson; V Jønsson; E Hippe
Journal:  Immunol Today       Date:  1990-05

Review 9.  Interleukins. Clinical pharmacokinetics and practical implications.

Authors:  V Bocci
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

10.  Urinary IL-6: a marker for mesangial proliferative glomerulonephritis?

Authors:  C Gordon; N Richards; A J Howie; K Richardson; J Michael; D Adu; P Emery
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

View more
  1 in total

1.  Response of soluble IL-2 receptor, interleukin-2 and interleukin-6 in patients with positive and negative Borrelia burgdorferi serology.

Authors:  I Nilsson; M Alves; L Nässberger
Journal:  Infection       Date:  1994 Sep-Oct       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.